Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Researchers discover mechanism on how body’s antimicrobial shield regulates microbiome

Researchers discover mechanism on how body’s antimicrobial shield regulates microbiome

The microbiome in our intestine plays a vital role in people’s health and the immune system. Any lack of balance there has not only been linked to chronic inflammatory intestinal inflammation, but also type 2 diabetes and other diseases.

A group of researchers at the University Hospital Tübingen has now reported for the first time that they have discovered a mechanism on how the body’s own endogenous antimicrobial defense shield regulates the microbiome and its bacterial composition; the article has been published in a recent edition of “Proceedings” by the National Academy of Science USA” (PNAS). This mechanism provides a fundamental understanding of the structure of the intestinal barrier and host microbial interaction. “It throws open the door for future approaches to new treatments, but also for developing antibiotics and beneficial microbiome modulation,” says the head of the working group, Professor Dr. med. Jan Wehkamp from University Hospital Tübingen.

Cluster bomb effect of defensin HD-5 strengthens the immune system

The researchers discovered a new “cluster bomb” like effect created by the body’s own antibiotics, the so-called defensins (peptides), which are formed and secreted in the Paneth granule cells, in the small intestine. “The HD-5 defensin, which the body produces naturally and releases in the intestine, splinters into fragments if it is exposed to bacteria in the gastrointestinal wall in certain circumstances. These fragments do not, however, consist of ineffective waste, as was thought in the past, but they have an antimicrobial effect against commensal, harmless bacteria and bacteria that are pathogenic,” says Prof. Wehkamp, describing the discovery. The researchers have found 250 new antibiotic combinations in all in the different fragments, when examining them in a laboratory. “This mechanism dramatically increases the antimicrobial spectrum against possible intruders,” Wehkamp adds.

The working group in Tübingen, which has been conducting research into the microbiome for many years, was already able to publish an article in “Nature” in 2011 indicating that defensins play an important role in maintaining the balance between bacteria and the body surfaces in all organisms, particularly in the intestine (but not only there).

The scientists use the latest publication in PNAS to demonstrate how the prevailing conditions inside our intestines affect the activity and structure of the peptides: In reduced conditions with only limited oxygen – a situation that often occurs in the intestine – the HD-5 peptide, which was originally secreted in a folded (oxidized) form, is opened and activated. It becomes more prone to degrading through its new linear structure: As a result, the proteases occurring in the intestinal mucus layer can break up the HD-5 defensin into many fragments – so activating this antimicrobial weapon. Out of one peptide the body creates endless combinations of attacking and controlling microboes which is a very smart and efficient way of defense.

Nothing passes through the HD-6 defensin net

Interestingly, nature has created a completely different defense mechanism in the other Paneth cell defensin peptide – defensin HD-6: In contrast to HD-5 it is protected from any degradation by the proteases because it is able to form an impenetrable net. The scientists report that the HD-6 defensin remains completely stable in the natural gastrointestinal mucus, while HD-5 is broken down into fragments in the same location.

The researchers were able to artificially produce individual fragments of the HD-5 defensin during a following stage and exposed them to different kinds of bacteria. The results were impressive: The fragments demonstrated amazing, variable, antimicrobial activity against harmless and pathogenic bacteria, including gram-negative bacteria, which are notorious for forming resistance to antibiotics.

Greater variety of intestinal flora in mice

The working group in Tübingen was also able to prove that HD-5 fragments affect the composition of bacteria in the intestine of mice and increase the variety of flora in the small intestine. A particular HD-5 fragment was fed to mice orally, for instance – in contrast to a control group, which received normal food. The results were surprising: Administering the fragment led to a higher proportion of akkermansia sp. bacteria in the intestine of the mice. A decrease in the presence of these “good” bacteria had been associated with various diseases like diabetes mellitus and metabolic syndrome in earlier studies. “The fragmentation increases the variability of the antimicrobial defenses, particularly because the initial peptide is one of the most commonly produced and secreted peptides in the whole organism,” says Jan Wehkamp.

Treatment opportunities and new antibiotics

“This pioneer work has opened the door to an entirely new understanding of how host defense functions when confronted by bacteria, but also how the microbiome is regulated. This will be very interesting, as an enormous amount of research work is taking place on the microbiome around the globe,” says Jan Wehkamp, summarizing developments. The discovery made by the group in Tübingen opens up opportunities of finding new antibiotic substances as modulators of the microbiome or new types of antibiotics.

However, the ongoing analysis of fragments of antimicrobial peptides and their role in providing defenses against microorganisms – including possible approaches to treatment for bacteria that are resistant to antibiotics – is only at a very early stage. It is easy to reproduce the fragments discovered by the working group in Tübingen and they could play a role in treating various diseases in the future.

The work of the group, is part of Jan Wehkamp’s Heisenberg Professorship for Innate Immunity at the Medical University Clinic at Tübingen, is also originated as part of the Research Excellence Cluster at the University of Tübingen.

Source:

https://uni-tuebingen.de/

Tagged with:

About author

Related Articles